Form 8-K - Current report:
SEC Accession No. 0001367644-16-000076
Filing Date
2016-09-30
Accepted
2016-09-30 09:21:24
Documents
2
Period of Report
2016-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8knuthraxpr.htm 8-K 23947
2 ex99.htm EX-99 38272
  Complete submission text file 0001367644-16-000076.txt   63382
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 161911422
SIC: 2834 Pharmaceutical Preparations